国产一区二区三区视频精品-国产一区二区三区视频在线观看-国产一区二区三区四区五区-国产一区二区三区四区五区精品-国产一区二区三区无码免费-国产一区二区三区在线

美國Accumetrics  
Accumetrics 致力于通過提供業(yè)界領(lǐng)先且廣泛可用的快速評估血小板功能的診斷檢測方法，來促進(jìn)醫(yī)學(xué)界對血小板功能的了解，并提高對正在接受抗血小板治療的患者的護(hù)理質(zhì)量。

Accumetrics 的 VerifyNow System 是幫助醫(yī)生判定個體患者對多種抗血小板藥物反應(yīng)的首個快速且易于使用的平臺。VerifyNow System 適用于各種主要的抗血小板藥，包括獲得 FDA 批準(zhǔn)的阿司匹林產(chǎn)品、P2Y12 抑制劑（如 prasugrel (Effient) 和 clopidogrel (Plavix)）、以及 GP IIb/IIIa 抑制劑（如 ReoPro(R) 和 Integrilin(R)），提供了一種可以幫助醫(yī)生做出明智治療決定的寶貴工具。

Accumetrics is at the forefront of revolutionizing the way doctors manage the tens of millions of patients who take antiplatelet drugs to prevent heart attack, stroke and other potentially life-threatening cardiovascular events.

Accumetrics is a privately-held company based in San Diego, California. The company develops, manufactures, and markets the VerifyNow? System, a comprehensive suite of tests for the assessment of platelet response to antiplatelet therapies. The tests are fully automated and easy-to-use allowing physicians an accurate way to assess platelet response to optimize the effectiveness of antiplatelet therapies, and to guide treatment decisions in patients who may be at risk of a life threatening thrombosis event or bleeding complication.